Alumis ALMS
NASDAQ ALMS
$9.90 +0.10 (+1.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Alumis (ALMS) Profit After Tax (2023 - 2026)

Alumis' (ALMS) quarterly Profit After Tax came in at -$142.4 million in Q2 2026, down 339.99% year-over-year from $59.4 million in Q2 2025, and down 51.37% quarter-over-quarter from -$94.1 million in Q4 2025.

Analysis

Alumis (ALMS) Profit After Tax (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Profit After Tax for 4 consecutive years, with -$142.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 339.99% year-over-year to -$142.4 million in Q2 2026; TTM through Jun 2026 was -$288.0 million, a 18.49% increase from a year earlier, with the FY2025 full-year figure at -$475.1 million, down 20.53% from the prior year.
  • Profit After Tax was -$142.4 million for Q2 2026 at Alumis, down from -$94.1 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $59.4 million in Q2 2025 and troughed at -$172.1 million in Q4 2024.
  • A 4-year average of -$77.2 million and a median of -$75.3 million in 2024 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax jumped 205.03% in 2025 and slumped 339.99% in 2026, its largest moves.
  • Over 4 years, Profit After Tax stood at -$39.3 million in 2023, then sank by 337.79% to -$172.1 million in 2024, then jumped by 45.31% to -$94.1 million in 2025, then tumbled by 51.37% to -$142.4 million in 2026.
  • The last three Profit After Tax figures came in at -$142.4 million (Q2 2026), -$94.1 million (Q4 2025), and -$110.8 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 472.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -290.61 Mn
10 Alumis 1.27 Bn 765.76 Mn - -142.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.44 Mn
Dec 31, 2025 -94.10 Mn
Sep 30, 2025 -110.80 Mn
Jun 30, 2025 59.35 Mn
Mar 31, 2025 -98.96 Mn
Dec 31, 2024 -172.05 Mn
Sep 30, 2024 -141.67 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -49.85 Mn
Dec 31, 2023 -39.30 Mn
Sep 30, 2023 -43.40 Mn
Jun 30, 2023 -36.29 Mn